Su F, Su M, Wei W, Wu J, Chen L, Sun X
Gut Microbes. 2025; 17(1):2476570.
PMID: 40063366
PMC: 11901428.
DOI: 10.1080/19490976.2025.2476570.
Sabit H, Arneth B, Altrawy A, Ghazy A, Abdelazeem R, Adel A
Biomedicines. 2025; 13(2).
PMID: 40002898
PMC: 11852909.
DOI: 10.3390/biomedicines13020485.
Nilsson A, Meimetis N, Lauffenburger D
NPJ Precis Oncol. 2025; 9(1):46.
PMID: 39948231
PMC: 11825879.
DOI: 10.1038/s41698-025-00822-y.
Bumbaca B, Huggins J, Birtwistle M, Gallo J
NPJ Syst Biol Appl. 2025; 11(1):14.
PMID: 39893170
PMC: 11787326.
DOI: 10.1038/s41540-025-00493-2.
De Domenico M, Allegri L, Caldarelli G, dAndrea V, Di Camillo B, Rocha L
NPJ Digit Med. 2025; 8(1):37.
PMID: 39825012
PMC: 11742446.
DOI: 10.1038/s41746-024-01402-3.
Integrating multi-omics to unravel host-microbiome interactions in inflammatory bowel disease.
Zhang Y, Thomas J, Korcsmaros T, Gul L
Cell Rep Med. 2024; 5(9):101738.
PMID: 39293401
PMC: 11525031.
DOI: 10.1016/j.xcrm.2024.101738.
AutoFocus: a hierarchical framework to explore multi-omic disease associations spanning multiple scales of biomolecular interaction.
Schweickart A, Chetnik K, Batra R, Kaddurah-Daouk R, Suhre K, Halama A
Commun Biol. 2024; 7(1):1094.
PMID: 39237774
PMC: 11377741.
DOI: 10.1038/s42003-024-06724-2.
LIANA+ provides an all-in-one framework for cell-cell communication inference.
Dimitrov D, Schafer P, Farr E, Rodriguez-Mier P, Lobentanzer S, Badia-I-Mompel P
Nat Cell Biol. 2024; 26(9):1613-1622.
PMID: 39223377
PMC: 11392821.
DOI: 10.1038/s41556-024-01469-w.
SignalingProfiler 2.0 a network-based approach to bridge multi-omics data to phenotypic hallmarks.
Venafra V, Sacco F, Perfetto L
NPJ Syst Biol Appl. 2024; 10(1):95.
PMID: 39179556
PMC: 11343843.
DOI: 10.1038/s41540-024-00417-6.
Unveiling hidden connections in omics data via pyPARAGON: an integrative hybrid approach for disease network construction.
Arici M, Tuncbag N
Brief Bioinform. 2024; 25(5).
PMID: 39163205
PMC: 11334722.
DOI: 10.1093/bib/bbae399.
Extracellular Matrix Sulfation in the Tumor Microenvironment Stimulates Cancer Stemness and Invasiveness.
Kusoglu A, Ornek D, Dansik A, Uzun C, Nur Ozkan S, Sarica S
Adv Sci (Weinh). 2024; 11(36):e2309966.
PMID: 39083319
PMC: 11423251.
DOI: 10.1002/advs.202309966.
MetalinksDB: a flexible and contextualizable resource of metabolite-protein interactions.
Farr E, Dimitrov D, Schmidt C, Turei D, Lobentanzer S, Dugourd A
Brief Bioinform. 2024; 25(4).
PMID: 39038934
PMC: 11262834.
DOI: 10.1093/bib/bbae347.
Review: Cancer and neurodevelopmental disorders: multi-scale reasoning and computational guide.
Nussinov R, Yavuz B, Demirel H, Arici M, Jang H, Tuncbag N
Front Cell Dev Biol. 2024; 12:1376639.
PMID: 39015651
PMC: 11249571.
DOI: 10.3389/fcell.2024.1376639.
A practical introduction to holo-omics.
Odriozola I, Rasmussen J, Gilbert M, Limborg M, Alberdi A
Cell Rep Methods. 2024; 4(7):100820.
PMID: 38986611
PMC: 11294832.
DOI: 10.1016/j.crmeth.2024.100820.
Comparative analysis of integrative classification methods for multi-omics data.
Novoloaca A, Broc C, Beloeil L, Yu W, Becker J
Brief Bioinform. 2024; 25(4).
PMID: 38985929
PMC: 11234228.
DOI: 10.1093/bib/bbae331.
Memory effects of prior subculture may impact the quality of multiomic perturbation profiles.
Bortel P, Hagn G, Skos L, Bileck A, Paulitschke V, Paulitschke P
Proc Natl Acad Sci U S A. 2024; 121(29):e2313851121.
PMID: 38976734
PMC: 11260104.
DOI: 10.1073/pnas.2313851121.
A single-sample workflow for joint metabolomic and proteomic analysis of clinical specimens.
Gegner H, Naake T, Aljakouch K, Dugourd A, Kliewer G, Muller T
Clin Proteomics. 2024; 21(1):49.
PMID: 38969985
PMC: 11225228.
DOI: 10.1186/s12014-024-09501-9.
MPAC: a computational framework for inferring cancer pathway activities from multi-omic data.
Liu P, Page D, Ahlquist P, Ong I, Gitter A
bioRxiv. 2024; .
PMID: 38948762
PMC: 11212914.
DOI: 10.1101/2024.06.15.599113.
Machine learning integrative approaches to advance computational immunology.
Curion F, Theis F
Genome Med. 2024; 16(1):80.
PMID: 38862979
PMC: 11165829.
DOI: 10.1186/s13073-024-01350-3.
Network Analyses of Brain Tumor Patients' Multiomic Data Reveals Pharmacological Opportunities to Alter Cell State Transitions.
Bumbaca B, Birtwistle M, Gallo J
Res Sq. 2024; .
PMID: 38826227
PMC: 11142360.
DOI: 10.21203/rs.3.rs-4391296/v1.